Personalized Medicine Coalition

Thank you for joining us!

As the 18th Annual Personalized Medicine Conference comes to a close, we reflect on the journey we embarked on over the last 20+ years. From the early days of understanding genetic markers to the current advancements in AI, diagnostics, and healthcare delivery, the progress in personalized medicine has truly transformed the landscape for research, drug development and healthcare, making treatments more precise, effective, and individualized. We've seen the development of targeted therapies that have not only improved patient outcomes but have also paved the way for a future where healthcare is tailored to the unique needs of each patient. But the gap between what is scientifically possible and what is clinically practiced remains far too large. As we look to the future, let’s continue to collaborate, innovate, and find ways to bring the benefits of personalized medicine to more patients. Together, we can achieve a future where personalized medicine is not just a vision, but a reality for all. Thank you to everyone who participated and contributed to the success of this conference. Your dedication and passion are what make these advances possible. We look forward to continuing this dialogue and pioneering the new approaches, pathways and collaborations needed to foster continued progress in the field. We will see you at next year’s Personalized Medicine Conference – November 13-14, 2025 –in Dana Point, California. #PMC2024 #PersonalizedMedicine #FutureOfMedicine #PMC2025

It was an inspiring morning at the Personalized Medicine Conference where we took a deeper dive into the incredible progress made since the sequencing of the human genome 20 years ago and today’s ongoing efforts to apply scientific advances in the field. One example is the work underway to develop blood-based cancer screening tools which hold the promise to detect cancers before symptoms appear. The collaboration between GRAIL and Point32Health underscores the critical role partnerships play in piloting and evaluating innovative tools to help shape a pathway to deliver these advances to patients. Foundational to continued progress is sustained leadership in navigating the dynamic scientific, economic, and political landscapes both in Washington, D.C. and globally. As an emergency medicine physician, Michael Ybarra, MD, Chief Medical Officer at PhRMA, has seen first hand how personalized treatments for cystic fibrosis and sickle cell anemia have revolutionized care for patients living with these diseases. He emphasized the importance of adaptive strategies and collaborative efforts to drive R&D forward. These discussions are pivotal as we continue to push the boundaries of personalized medicine, aiming for a future where healthcare is tailored to each individual's unique genetic makeup. #PMC2024 #PersonalizedMedicine #HealthcareInnovation #CancerScreening

Closing out Day 1 with panelists delving into the transformative potential of AI in healthcare and personalized medicine, including: ? Pattern Recognition: How AI is recognizing patterns that often go unnoticed by physicians, solving critical issues in diagnostics, pathology and other areas of practice. ? Efficiency Enhancements: AI is performing tasks that humans could only achieve if time, experts, and resources were limitless. ? New AI Models: By having foundational models trained in the language of biology, we can drive innovation in silico. ? Generative AI: How it is accelerating the ability to scale and extract valuable insights, pushing the boundaries of what's possible in personalized medicine. Thank you to all participants and speakers who contributed to a successful first day of the Personalized Medicine Conference. Day 2 promises a continuation of engaging discussions, focusing on the systemic response to personalized medicine adoption and implementation. #PMC2024 #PersonalizedMedicine #HealthcareInnovation

It’s with great honor and pride that we recognize?Emily Kramer-Golinkoff,?Co-Founder of?Emily's Entourage, as the recipient of this year’s Annual Award for Leadership in Personalized Medicine. This accolade is presented to individuals whose remarkable contributions in science, business, policy, and advocacy have driven the limits of personalized medicine. ? Emily has made significant strides in the field of cystic fibrosis (CF), particularly focusing on rare nonsense mutations. Diagnosed with a rare mutation of CF herself, Emily has used her personal experience to drive groundbreaking research and advocacy. Through Emily's Entourage, she has accelerated the development of life-saving treatments by raising millions of dollars and fostering collaborations with top researchers, pharmaceutical companies, and the CF community. ? Genevieve Mack?accepted the award on behalf of Emily from?Brian Munroe, PMC Founder & Board Member, recognizing Emily's relentless efforts to transform the landscape of CF research and her dedication to finding a cure for all CF patients, especially those with rare mutations. This honor underscores her impact on advancing personalized treatments and improving the lives of countless individuals living with CF. ? Congratulations once again to Emily on this well-deserved honor! ? #PMC2024 #PersonalizedMedicine ?

Today is the official kickoff of the 18th Annual Personalized Medicine Conference with a full day of discussions covering important topics from genomics to the latest in AI-driven diagnostics to precision oncology and patient-centered care. We look forward to convening leaders each year at this forum to catalyze an invaluable dialogue on the transformation of biomedical innovation and personalized medicine. ? As we reflect on the progress made and the challenges that lie ahead, we continue to be inspired by the steadfast commitment of industry, researchers, patient advocates, and policymakers to drive positive change and improved patient outcomes through personalized medicine. ? Feel free to reach out, share your thoughts and let’s make the most out of these next two days! #PMC2024 #PersonalizedMedicine Edward Abrahams Clifton Leaf Jacob Thaysen, PhD David Reese

Last night, we had an incredible welcome reception that set the tone for the next two days of insightful panel discussions at the 18th Annual Personalized Medicine Conference. It was wonderful to reconnect with colleagues and see new faces who are just as passionate about shaping the future of medicine. The evening was filled with a palpable sense of excitement for what's on the horizon fueled by personalized approaches to research and care. We’re especially looking forward to today's sessions on integrating AI in clinical practice and the future of gene therapy. ? Here's to a great start and the week ahead! ? #PMC2024 #PersonalizedMedicine Edward Abrahams Amy Nicole Nayar PharmD, HEOR Lincoln Nadauld Toni Andreu

On this, the first day of the Annual Personalized Medicine Conference, PMC is pleased to announce that Amy Nicole Nayar PharmD, HEOR, a pioneering health care leader known for her strategic approach to driving collective impact, will serve as the Coalition's next President & CEO. Amy Nicole will be with us during the conference, beginning tonight with a welcome reception at Boston's Hotel Commonwealth. Please join us in welcoming her to the team! Learn more about Amy Nicole at: https://lnkd.in/erWUmjMv #PersonalizedMedicine #PMC2024

#PMC2024 #PersonalizedMedicine

Twenty years ago, when President Clinton announced the mapping of the human genome, The New York Times declared it would “revolutionize the practice of medicine". Many of us shared this ambitious vision that could and would transform medicine as we know it. I have the privilege and honor of joining Mark Levin and janet woodcock this Thursday in Boston to reflect on this amazing journey. Together, we have seen this field evolve from an inspiring possibility to a healthcare reality that now includes more than 100,000 molecular tests and 300 personalized medicines. The path has not always been straight or smooth. As Machiavelli said, ‘there is nothing more difficult... than to take the lead in a new order of things’. But the progress has been remarkable, and the prospects ahead are even brighter. Join us on November 14th, as part of the 18th annual conference of the Personalized Medicine Coalition at Harvard Medical School's Joseph B. Martin Conference Center as we discuss where we've been, where we are and more importantly, where we are headed. https://lnkd.in/er7_wGmY